Release Date: 10/12/12 12:37 Summary: WAM: PRV S/holders overwhelmingly approve merger Price Sensitive: No Download Document 21.88KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%